Clinical Trial Update: Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether a sodium bicarbonate bolus can prevent contrast-induced nephropathy in patients undergoing emergent coronary procedures, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Osaka General Medical Center | Conditions: Emergent Coronary Procedure | Phase 4 | Status: COMPLETED | Results posted: 2010-07-09